These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 377683)
21. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect. Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385 [TBL] [Abstract][Full Text] [Related]
22. Procurement of runt disease of maternal origin. Beer AE; Billingham RE Transplant Proc; 1973 Mar; 5(1):887-91. PubMed ID: 4572151 [No Abstract] [Full Text] [Related]
23. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Wood ML; Monaco AP; Gozzo JJ; Liegeois A Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508 [No Abstract] [Full Text] [Related]
24. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM; Waller EK Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [TBL] [Abstract][Full Text] [Related]
25. Neonatal tolerance induction in diabetes-prone BB rats as a model for donor-specific pancreas transplantation during adulthood. Nakai I; Oka T; Field JM; Najarian JS; Sutherland DE; Brayman KL Transplant Proc; 1992 Dec; 24(6):2902. PubMed ID: 1465991 [No Abstract] [Full Text] [Related]
26. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Li JM; Gorechlad J; Larsen CP; Waller EK Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205 [TBL] [Abstract][Full Text] [Related]
27. Tolerance manifestations among inbred rat strains defined in the Rt H-1 antigens. I. Runt syndrome incidence and skin graft tolerance. Kren V; Stark O; Krenová D Folia Biol (Krakow); 1969; 17(3):188-96. PubMed ID: 5801812 [No Abstract] [Full Text] [Related]
28. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2. Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666 [TBL] [Abstract][Full Text] [Related]
29. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells. Williams FH; Thiele DL Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273 [TBL] [Abstract][Full Text] [Related]
30. Marrow grafts between histoincompatible canine family members. Storb R; Kolb HJ; Graham TC; Leblond R; Kolb H; Lerner KG; Thomas ED Rev Eur Etud Clin Biol; 1972; 17(7):680-5. PubMed ID: 4568108 [No Abstract] [Full Text] [Related]
31. Longevity of AKR mice increased by reduced incidence of thymic lymphomas. A preliminary report. Uphoff DE Transplantation; 1969 Aug; 8(2):203-4. PubMed ID: 4896334 [No Abstract] [Full Text] [Related]
32. The impact of major histocompatibility complex (MHC) and non-MHC antigenic differences on graft-versus-host disease mediated by helper T cells. Thiele DL; Lipsky PE Trans Assoc Am Physicians; 1989; 102():59-67. PubMed ID: 2534709 [No Abstract] [Full Text] [Related]
33. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells. Liu YP; Li Z; Nador RG; Strober S Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541 [TBL] [Abstract][Full Text] [Related]
34. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Hess AD Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597 [TBL] [Abstract][Full Text] [Related]
35. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow. Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532 [TBL] [Abstract][Full Text] [Related]
37. Histoincompatible skin and marrow grafts in mice given cholera toxin. Tsuru S; Taniguchi M; Shinomiya N; Takemura T; Togami M Transplant Proc; 1989 Feb; 21(1 Pt 1):1158-60. PubMed ID: 2650084 [No Abstract] [Full Text] [Related]
38. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573 [TBL] [Abstract][Full Text] [Related]
39. Immunofluorescence and elution studies in tetraparental NZB forms and is formed from CFW chimaeras and graft-versus-host diseased NZB. Barnes RD; Holliday J; Tuffrey M Immunology; 1974 Jun; 26(6):1195-206. PubMed ID: 4368790 [TBL] [Abstract][Full Text] [Related]
40. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization. Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]